Business Context and Reporting Period
Alpha Tau Medical Ltd. filed Form 6-K on September 28, 2022, covering the month of September 2022. The filing furnishes materials for the company’s annual general meeting of shareholders scheduled for November 2, 2022, at the company’s headquarters in Jerusalem, Israel.
Financial and Operating Metrics
This Form 6-K does not provide financial statements, revenue, profit or loss, cash flow, margins, debt, liquidity, or other operating metrics. The filing is administrative and relates to annual meeting materials.
Material Changes Versus the Prior Comparable Period
The filing text does not report financial or operational changes versus a prior period.
Guidance, Outlook, Risks, and Unusual Items
The filing does not provide management guidance, an outlook, risk updates, contingencies, or unusual financial items. It includes a notice and proxy statement describing meeting proposals and procedures for voting in person or by proxy.
Exhibits and Corporate Actions
- Exhibit 99.1: Notice and proxy statement for the November 2, 2022 annual general meeting.
- Exhibit 99.2: Proxy card for beneficial holders.
- Exhibit 99.3: Proxy card for registered holders.
- The Form 6-K is incorporated by reference into the company’s Form S-8 registration statement, File No. 333-264169.
Investor Verification Checklist
- Review the proxy statement for the specific proposals submitted to shareholders.
- Confirm the meeting date, time, location, voting eligibility, and proxy submission procedures.
- Consult the company’s applicable periodic filings for current financial results, liquidity, capital resources, debt, risks, and business developments, as these are not included here.